SciELO - Scientific Electronic Library Online

 
vol.20 número4Ertapenem: Una nueva clase de carbapenemCosto de las infecciones intrahospitalarias en hospitales chilenos de alta y mediana complejidad índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

MINISTERIO DE SALUD. COMISIÓN NACIONAL DEL SIDA. Impact evaluation of a public policy: Expanding access to antiretroviral therapy. Rev. chil. infectol. [online]. 2003, vol.20, n.4, pp.277-284. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182003000400009.

The Comisión Nacional de SIDA-CONASIDA (Chilean AIDS National Comission) directs its efforts into prevention campaigns and medical assistance to HIV positive persons. The general policy for their assistance has been to optimize resources, to make a national protocol of antiretroviral therapy (ARVT) with the advice of scientific societies, to unify the acquisition of antiretroviral drugs and to deal with the pharmaceutical companies their prices. About 80 percent of patients are assisted by the national public health system and the resting 20 percent concur to private medicine services. Anti retroviral therapy has been optimized as follows: in 1992 mono-therapy was started, in 1997 it was changed to bi-therapy and in 1999 tri-therapy begun. In 2002 5080 HIV positive persons were under control by the public health system and in december 2000 tri-therapy reached 91,2% of coverage in whom it was prescribed. The positive impact of this program has been reflected in a 39 percent reduction of hospitalization, the increasing access to CD4 and viral load periodical determinations, delay in AIDS appearance and diminishing deaths due to AIDS.

Palabras clave : AIDS; National program; Antiretroviral therapy; Impact.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons